David Horrobin Bibliography
1996
690
Bordoni, A.; Lopez-Jimenez, J.A.; Spano, C.; Biagi, P.L.; Horrobin, D.F.; Hrelia, S.
Metabolism of linoleic and alpha-linolenic acids in cultured cardiomyocytes: Effect of different n-6 and n-3 fatty acid supplementation
Mol Cell Biochem 1996; 157(1-2): 217-222.
(Abstract)


691
Cantrill, R.C.; Patterson, P.P.; Ells, G.W.; Horrobin, D.F.
Exogenous gamma-linolenic acid alters hormone stimulated cyclic AMP levels in U937 cells
Cancer Lett 1996; 100(1-2): 17-21.
(Abstract)


692
Ells, G.W.; Chisholm, K.A.; Simmons, V.A.; Horrobin, D.F.
Vitamin E blocks the cytotoxic effect of gamma-linolenic acid when administered as late as the time of onset of cell death - insight into the mechanism of fatty acid induced cytotoxicity
Cancer Lett 1996; 98(2): 207-211.
(Abstract)


693
Fievet, P.; Horrobin, D.F.; Stewart, J.C.; Moss, M.; Fournier, A.
Fatty acid profile of erythrocyte membrane phospholipids in normal pregnancy and pregnancy induced hypertension, effect of evening primrose oil
International Society for the Study of Hypertension in Pregnancy. IXth International congress, Sydney, Australia 1996.


694
Glen, A.I.M.; Cooper, S.J.; Rybakowski, J.; Vaddadi, K.; Brayshaw, N.; Horrobin, D.F.
Membrane fatty acids, niacin flushing and clinical parameters
Prostaglandins Leukotr EFAs 1996; 15(1-2): 9-15.
(Abstract)


695
Horrobin, D.F.
High levels of polyunsaturated fat may inhibit cancer growth [letter]
Br Med J 1996; 312(7029): 511.
(Full text)  

696
Horrobin, D.F.
Calcium metabolism, osteoporosis and essential fatty acids: a review [review]
Congress on osteoporosis. 27-28 Sept. 1996 Bakubung, South Africa 1996; 27-28 Sept(session IV): 41-44.


697
Horrobin, D.F.
Ascorbic acid and prostaglandin synthesis
In: Subcellular Biochemistry (Vol. 25). Harris RJ (Ed). Ascorbic Acid:Biochemistry and Biomedical Cell Biology, Plenum Press, New York 1996: 109-15.


698
Horrobin, D.F.
Peer review of grant applications: a harbinger for mediocrity in clinical research ?
Lancet 1996; 348: 1293-1295.


699
Horrobin, D.F.
Lipids as pharmaceuticals
LipidForum 1996; 51(Spring): 6-10.


700
Horrobin, D.F.
The philosophical basis of drug target selection
Pharmaceutical Medicine 1996; 10: 29-42.


701
Horrobin, D.F.
The commercial development of food plants used as medicines
Plants for Food and Medicine, London, 1-6 July 1996.
(Abstract)


702
Horrobin, D.F.
Schizophrenia as a membrane lipid disorder which is expressed throughout the body [review]
Prostaglandins Leukotr EFAs 1996; 55(1&2): 3-7.
(Abstract)


703
Horrobin, D.F.
Ascorbic acid and prostaglandin synthesis [review]
Subcell Biochem 1996; 25: 109-15.


704
Horrobin, D.F. and Glen, A.I.M.
Biochemical markers for negative symptoms in schizophrenia
In: Kane, J.M.; Moller, H.-J.; Awouters, F. (Eds). Serotonin in Antipsychotic Treatment. Marcel Dekker Inc, New York. 1996: 211-219.


705
Horrobin, D.F.; Mahadik, S.; Reddy, R.; van Kammen, D.
In memoriam: Sukdeb Mukherjee MD, 1946-1995
Prostaglandins Leukotr EFAs 1996; 55(1&2): 1.


706
Hrelia, S.; Bordoni, A.; Biagi, P.; Rossi, C.A.; Bernardi, L.; Horrobin, D.F.; Pession, A.
Gamma-linolenic acid supplementation can affect cancer cell proliferation via modification of fatty acid composition
Biochem Biophys Res Comm 1996; 225(2): 441-447.
(Abstract)


707
Hudson, C.J.; Kennedy, J.L.; Gotowiec, A.; Lin, A.; King, N.; Gojtan, K.; Macciardi, F.; Skorecki, K.; Meltzerl, H.Y.; Warsh, J.J.; Horrobin, D.F.
Genetic variant near cytosolic phospholipase A2 associated with schizophrenia
Schizophr Res 1996; 21(2): 111-116.
(Abstract)


708
Hudson, C.J.; Lin, A.; Horrobin, D.F.
Phospholipases: in search of a genetic base of schizophrenia
Prostaglandins Leukotr EFAs 1996; 55(1-2): 119-122.
(Abstract)


709
Jiang, W.G.; Bryce, R.P.; Horrobin, D.F.; Mansel, R.E.
Regulation of gap junction communication in endothelial and tumour-endothelial interaction by gamma linolenic acid.
Breast Cancer Research and Treatment 1996; 41(3): 267.


710
Jiang, W.G.; Hiscox, S.; Bryce, R.P.; Horrobin, D.F.; Mansel, R.E.
Gamma linolenic acid (GLA) regulates the expression of NM23 and in vitro invasion of breast cancer cells
Breast Cancer Research and Treatment 1996; 41(3): 282.


711
Jiang, W.G.; Hiscox, S.; Hallett, M.B.; Scott, C.; Horrobin, D.F.; Puntis, M.C.A.
Modulation of motility, invasion and growth by n-6 essential fatty acids on human cancer cells
Proceedings of the International Symposium on Cancer Research and New Trends of Treatment 1996: 60.


712
Jiang, W.G.; Hiscox, S.; Puntis, M.C.A.; Bryce, R.P.; Horrobin, D.F.; Mansel, R.E.; Hallett, M.B.
Inhibition of membrane ruffling and ezrin translocation by gamma linolenic acid
Int J Oncol 1996; 9: 279-284.


713
Jiang, W.G.; Hiscox, S.; Puntis, M.C.A.; Hallett, M.B.; Bryce, R.; Horrobin, D.F.; Mansel, R.E.
Gamma linolenic acid inhibits tyrosine phosphorylation of focal adhesion kinase and paxillin and tumour cell matrix interaction
Int J Oncol 1996; 8: 583-587.


714
Jiang, W.G.; Hiscox, S.; Puntis, M.C.A.; Horrobin, D.F.; Hallett, M.B.; Mansel, R.E.
Expression of E-cadherin, alpha-, beta-, and gamma-catenins in human breast cancer cells and their regulation by gamma linolenic acid
Breast Cancer Research and Treatment 1996; 37(SS): 84.


715
Jiang, W.G.; Puntis, M.C.A.; Horrobin, D.F.; Scott, C.; Hallett, M.B.
Inhibition of neutrophil respiratory burst and cytokine priming by gamma-linolenic acid
Br J Surgery 1996; 83(5): 659-664.
(Abstract)


716
Mahadik, S.P.; Mukherjee, S.; Horrobin, D.F.; Jenkins, K.; Correnti, E.E.; Scheffer, R.E.
Plasma membrane phospholipid fatty acid composition of cultured skin fibroblasts from schizophrenic patients: Comparison with bipolar patients and normal subjects
Psychiatry Research 1996; 63(2-3): 133-142.
(Abstract)


717
Mowat, B.; Wilson, H.M.; Skinner, E.R.; Leng, G.; Gerry, F.; Fowkes, R.; Horrobin, D.
Alterations in plasma lipoprotein concentrations in patients with peripheral vascular disease
Biochem Soc Trans 1996; 24(2): 154S.


718
Mowat, B.F.; Skinner, E.R.; Watt, C.; Corrigan, F.M.; van Rhijn, A.G.; Cousland, G.; Horrobin, D.F.
Lipoprotein profiles in Alzheimer's disease: Lack of an effect of apolipoprotein E4 phenotype on the distribution of high density lipoprotein subfractions
Alzheimer's Res 1996; 2(3): 89-93.


719
Nilsson, A.; Horrobin, D.F.; Rosengren, A.; Waller, L.; Adlerberth, A.; Wilhelmsen, L.
Essential fatty acids and abnormal involuntary movements in the general male population: a study of men born in 1933
Prostaglandins Leukotr EFAs 1996; 55(1-2): 83-87.
(Abstract)


720
Redden, P.R.; Lin, X.; Horrobin, D.F.
Comparison of the Grignard deacylation TLC and HPLC methods and high resolution 13C-NMR for the sn-2 positional analysis of triacylglycerols containing gamma-linolenic acid
Chem Physics Lipids 1996; 79(1): 9-19.
(Abstract)


721
Welsh, S.W.; Corrigan, F.M.; Smith, W.E.; Horrobin, D.F.
Plasma thiols, cognitive function and ageing
Clin Chim Acta 1996; 249(1-2): 183-187.




All copyrights acknowledged

© Peter Lapinskas 1999-2012 Email Peter Lapinskas Last updated: 3 July 2012

Home      Services      Background      Publications      Resources      Contact